Resources | vancomycin

Products
- For Providers
- For Life Sciences
Platform
Resources
Company
Press
- Media InsightRX in the news — digital, print, podcasts, and other outlets
- Press Releases Announcements for events, partnerships, and company updates

KLAS-emerging-company-spotlight

FEATURED POST

InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution

Home
Resources
Blog

Search Blog section Author Tags

Product Innovation

Aug 8, 2025

Improving Vancomycin Dosing in Pediatric Subpopulations (Part II): Guiding Model Selection in Oncology Patients

Product Innovation

Jul 30, 2025

Improving Vancomycin Dosing in Pediatric Subpopulations (Part I): Guiding Model Selection in CVICU Patients

Product Innovation

Jul 16, 2025

Elevating Precision Dosing for Hemodialysis Patients: A New Vancomycin CRRT Model

Thought Leadership

Apr 24, 2025

Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing

Thought Leadership

Sep 18, 2024

How well do AUC24 estimates and trough estimates correlate in vancomycin?

Thought Leadership

Jun 28, 2024

AUC Monitoring for Vancomycin: Comparing Estimation Methods

Product Innovation

Mar 11, 2022

2021 Year in Review and Recent Product Enhancements

Maximize therapeutic success with precision medicine.

What We Do

For Providers

Bayesian Dosing (MIPD)
Real-Time Dosing Analytics
Available Drug Modules

For Life Sciences

Precision Dosing in Clinical Trials
PKPD Analytics in Clinical Trials
Companion Applications

How We Do It

Continuous Learning
Integrations
Security & Regulatory
Success & Support
Data Science

Information

Resources

Product Innnovation
Scientific Publications
Thought Leadership
White Papers
How to Cite InsightRX

Press

Media
Press Releases

About

Contact Us
Customers
Leadership
Advisory Board
Mission & Vision
Careers

548 Market Street
#88083
San Francisco, CA 94104

Copyright © InsightRX, Inc.
740-05000-REC-01 08/2025

View our privacy policy

InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance

548 Market Street
#88083
San Francisco, CA 94104